BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 3
• 4
• 5
• 6
• 7
• 8
• 9
• 10
• 11
• 12
• 13
• 14
• 15
• 16
• 18
• 19
• 20
• 21
• 22
• 23
• 24
• 25
• 26
• 27
• 28
• 29
• 30

• 

  Complete Human Genome Sequence is in, and the Missing Pieces Are...

  The Telomere-to-Telomere (T2T) Consortium has completed the sequencing of the entire genome, referring to it as T2T-CHM13.

  April 1, 2022

   · 

  2 min read

   · 

  Jazmine Colatriano M.S.
• 

  Drug Development

  COVID-19 Update: New Kids Vaccine Data, Breakthrough Risk for Vaccinated Women

  Although the data suggests the vaccines are extremely effective and generally safe, analysis is still coming in about adverse events as well as effectiveness in specific patient populations.

  April 1, 2022

   · 

  5 min read

   · 

  Mark Terry
• 

  Drug Development

  FDA Delays Decision on Merck’s Pediatric Pneumococcal Vaccine

  The FDA requested additional data analyses from the pediatric studies that Merck stated it has submitted. The final decision is expected on July 1, 2022.

  April 1, 2022

   · 

  3 min read

   · 

  Hayley Shasteen
• 

  Job Trends

  Scrambling for Talent and More Office Space, Life Sciences Companies Relocate

  Dozens of life sciences companies are relocating to accommodate more employees and production capacities.

  April 1, 2022

   · 

  4 min read

   · 

  Hannah Chudleigh
• 

  Employer Resources

  How to Attract and Keep Top Talent in the Biopharma Industry

  The increased resignation of employees is making it difficult for companies to keep up with production and meet deadlines. Here are the best ways to attract and keep top talent in the pharma industry.

  April 1, 2022

   · 

  5 min read

   · 

  Franklin Carpenter
• 

  Policy

  Former MIT Researcher in Castor Beans Case Spared Prison

  Ishtiaq Ali Saaem is sentenced to three years of probation following a guilty plea to charges he obstructed a federal investigation into his efforts to acquire the deadly toxin ricin.

  April 1, 2022

   · 

  2 min read

   · 

  Alex Keown
• 

  Drug Development

  Human Challenge Study Reveals Potentially Key COVID-19 Data

  The landmark Human Challenge Programme deliberately exposed 36 young and healthy participants ages 18 to 30 with no immunity to the SARS-CoV-2 virus for 14 days.

  April 1, 2022

   · 

  3 min read

   · 

  Vanessa Doctor, RN
• 

  Drug Development

  Clinical Catch-Up: Adagio to Seek COVID-19 EUA, CytoDyn’s Bad Week

  It was a particularly busy week for clinical trial announcements. Let’s take a look.

  April 1, 2022

   · 

  13 min read

   · 

  Mark Terry
• 

  Business

  Silverback Halts Oncology Programs, Lays Off 27% Of Staff

  Silverback is halting its clinical oncology programs and letting go of about 27% of its workforce as part of a restructuring initiative that would leave it with more cash reserves.

  April 1, 2022

   · 

  2 min read

   · 

  Vanessa Doctor, RN
• 

  Business

  Ken Frazier Joins Board of Eikon, which is Looking Like “Merck 2.0"

  Kenneth Frazier, executive chairman and former chief executive officer of Merck, joins former colleagues Roger Perlmutter and Roy Baynes at the well-financed company.

  April 1, 2022

   · 

  3 min read

   · 

  Alex Keown